Multiple Myeloma Coverage from Every Angle

C. Ola Landgren, MD, PhD, on Managing a Complex Four-Agent Regimen in Myeloma

Posted: Thursday, January 2, 2020

C. Ola Landgren, MD, PhD, of Memorial Sloan Kettering Cancer Center, talks about the challenges of administering a complex regimen of oral and infused drugs, in varying doses throughout the cycle, for multiple myeloma.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.